Turkey aims to save $175m via 'base price' reimbursement
This article was originally published in Scrip
Executive Summary
Turkey has launched a "base price" reimbursement payment policy for key generics covering cardiovascular, respiratory and stomach ailments among others that aims to save the government TL400m ($175m) annually.